University of Patras
Μελέτη του ρόλου των συστατικών του μεταβολικού μονοπατιού της HDL στην παθογένεια της οστεοπόρωσης και της οστεοαρθρίτιδας
Abstract
dc:descriptionIntroduction: Recent data suggest that lipid metabolism imbalances affect osteoblast function and therefore may result in the development of degenerative and metabolic diseases such as osteoporosis. Osteoporosis is a common metabolic disease, which is characterized by low bone mass and progressive micro-architectural deterioration of bone, resulting in bone fragility and fracture susceptibility. Knowing the very important role of HDL (High Density Lipoprotein) in plasma and tissue lipid metabolism, in the present thesis we aim to assess the role of Apolipoprotein A1 (APOA1), vital component of HDL biosynthesis in the regulation of bone cells function and in the pathogenesis of osteoporosis in mice.Materials and Methods: We used ApoA1 deficient (ApoA1-/-) and wild-type (ApoA1+/+, WT) mice. Two and seven days before euthanasia calcein was injected intraperitonealy for the determination of new bone formation rate. Before euthanasia blood plasma was obtained and then animals were sacrificed. Following sacrifice, lumbar vertebrae and femora were removed and were used for histological, histomorphometrical, biomechanical, spectrometric and in vitro analyses. More specifically, we performed classical H&E staining to evaluate the morphology of the tissue and cells that comprise the environment of bone. In addition, using microCT scanner and static histomorphometry we evaluated the quality/quantity of the cortical and cancellous bone. In the tissue sections we performed histological (Η&Ε) and histochemical (TRAP) analyses for the determination of bone resorption areas. Dynamic histomorphometry (calcein labeling) was employed for the determination of bone quality and bone cell function. Using RAMAN spectroscopy, the quality and biochemical composition of the collagen fibers of the examined femora were evaluated between the two animal groups. The biomechanical properties of the examined femora were evaluated using 3-point bending test. Osteoclast precursors and bone marrow mesenchymal stem cells (MSC) were isolated, cultured and differentiated towards osteoclasts and osteoblasts/adipocytes, respectively. Using the different cell populations we assessed, in mRNA and protein level, the expression of osteoblastic (RUNX2, OSX, COL1A1), osteoclastic (OPG, RANKL, OPG/RANKL, RANK, TRAP, cathepsin Κ) and lipoblastic (PPARγ, CEBPA) regulators using Western Blotting, Flow Cytometry and qRT-PCR. Additionally, we evaluated the expression profile of genes associated with the cholesterol metabolic pathway (ApoA2, Ggps, Hmgcr, Hdlbp, Fdps1, Cpt1a, Scarb1) and genes which are involved in the maintenance and mobilization of MSC (Ptprc, Sca-1, Cxcl12, Cxcr4, Anxa2).Results: Bone mass was greatly reduced in ApoA1-/- mice relatively to wild type mice. ACTH was unaffected, though Scarb-1 mRNA in bone was greatly increased in ApoA1-/- mice. Static and dynamic histomorphometry showed that the reduced bone mass in ApoA1-/- mice, reflects decreased bone formation. Dynamic histomorphometry uncovered decreased osteoblast surface, bone formation and mineral apposition rate in ApoA1-/- mice. Notably, no changes were observed in osteoclast resorption areas. Biochemical composition and biomechanical properties of ApoA1-/- femora were impaired compared to the WT mice. Mesenchymal cell pool was similar between the two mouse groups. MSC differentiation from ApoA1-/- mice displayed significantly reduced osteoblasts, and increased adipocytes, relative to wild type, in identical differentiation conditions. This suggests a shift in MSC subtypes toward adipocyte precursors; increased adipocytes in ApoA1-/- mouse femora were consistent. Osteoclast differentiation in vitro and osteoclast surface in vivo were normal. In whole bone marrow cells, PPARγ was greatly increased, consistent with increased adipocytes and committed precursors. Furthermore, in the ApoA1-/- mice bone marrow, Cxcl12 mRNA level was decreased, while Cxcr4 mRNA level was increased, a finding consistent with reduced signaling in a pathway that supports MSC homing and osteoblast generation. In keeping, in the ApoA1-/- animals the osteoblast-related factors RUNX2, OSTERIX and COL1A1 were decreased. The ApoA1-/- phenotype also included increased CEPBa, furthermore supporting its lipoblastogenic effects.Conclusions: ApoA1 deficiency results in reduced bone mass, primarily due to reduced osteoblastic function. On the contrary ApoA1 deficiency results in increased adipogenesis and decreased osteoblastogenesis, resulting in impaired bone synthesis/quality, while osteoclast function remains unaffected. Our findings identify for the first time APOA1 as a key modulator of osteoblast and lipoblast function and raise the interesting possibility that APOA1 may be a potential therapeutic target for the treatment of osteoporosis and other metabolic diseases.
Degree
thesis:*- Grantor dc:publisher
- University of Patras
- Year dc:date
- 2017
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Kalyvioti, Eleni
- Καλυβιώτη, Ελένη
Subjects
dc:subject × 21Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/42084